Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)
This study aims to test the efficacy of a parent-based approach to treating Avoidant/Restrictive Food Intake Disorder (ARFID) in children, SPACE-ARFID (Supportive Parenting for Anxious Childhood Emotions, adapted for ARFID), by comparing it to Nutritional Support (NS). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
The primary objective is to examine if SPACE-ARFID is more efficacious than NS in reducing adolescent ARFID symptoms. The secondary objective is to examine if SPACE-ARFID produces greater change than NS in improving family accommodation and family functioning. SPACE and NS will be delivered over 16-20 weekly sessions, pre-assessment will take place before sessions begin and post-assessment will take place once sessions end, there will also be a midpoint assessment halfway through treatment (sessions 8-10) and one more follow-up assessment 6 months later.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Alison Magnotti, MA
- 電話番号:203-737-4644
- メール:alison.magnotti@yale.edu
研究連絡先のバックアップ
- 名前:Eli Lebowitz, PhD
- 電話番号:203-737-4644
- メール:eli.lebowitz@yale.edu
研究場所
-
-
Connecticut
-
New Haven、Connecticut、アメリカ、06519
- Yale Child Study Center
-
コンタクト:
- Eli Lebowitz, PhD
- 電話番号:203-737-4644
- メール:eli.lebowitz@yale.edu
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Be between 6 and 12 years old.
- Meet DSM-5 diagnostic criteria for ARFID, as determined by the PARDI diagnostic interview.
- Cease all other psychotherapeutic treatment targeting eating or feeding behaviors, upon consultation with project staff and the current service provider.
- Not currently use any psychotropic medication, unless on a stable dose for a minimum of 4 weeks prior to enrollment; no changes anticipated during the course of the study.
- BMI at or above the 5th percentile for age and sex.
- Have an eligible and willing participating parent (see parent exclusions below).
Exclusion Criteria:
Adolescents:
- Meet criteria for any other DSM-5 disorder as determined by the ADIS diagnostic interview and health history form, that is sufficiently impairing or disruptive so as to make treatment focused on ARFID not feasible.
- Have any of the following disorders: intellectual disability; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders, as determined by the health history form.
- Report a suicide attempt in the last 3 months, or current suicide intent and/or plans.
- Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Children and Families.
- Not have sufficient proficiency in English to complete assessments.
- Require a level of medical care for nutritional compromise that exceeds what can be safely provided in an outpatient setting.
Parents:
- Have any of the following: intellectual disability; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders, report a suicide attempt in the last 3 months, or current suicide intent and/or plans.
- Not be living with the child at least 50% of the time.
- Not have sufficient proficiency in English to complete assessments and participate in treatment.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Supportive Parenting for Anxious Childhood Emotions (SPACE)
Parent-only approach to treating anxiety disorders in adolescents delivered over 16-20 sessions. |
Parent-based treatment delivered by therapist for 16-20 weekly sessions. |
|
アクティブコンパレータ:Nutritional Support (NS)
Parent-only approach comparator arm delivered over 16-20 sessions. |
Nutritional Support from Registered Dietician for 16-20 weekly sessions with parents. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pica, ARFID, and Rumination Disorder Interview (PARDI-C/P)
時間枠:Weeks 1 and 16-20
|
This semi-structured clinical interview will assess ARFID presence and severity. Symptoms are rated on a 0 (no symptoms) to 6 (severe symptoms) scale. It yields an overall severity score and three profile scores (sensory sensitivity, lack of interest in eating or food, fear of aversive consequences). Score range = 0 to 6 with higher scores indicating greater severity. |
Weeks 1 and 16-20
|
|
Nine-Item Avoidant/Restrictive Food Intake Disorder Screen - Parent and Child Report (NIAS-C/P)
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This measure is a screener of ARFID severity. It contains 9 items, each rated on a 6-point scale from 0 ("strongly disagree") to 5 ("strongly agree"). It yields a total score and three subscale scores (picky/selective eating, poor appetite/limited interest, fear of negative consequences). Total score range = 0 to 45, with higher scores indicating greater severity. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Clinical Global Impression Scale - Severity (CGI-S) and Improvement (CGI-I)
時間枠:Weeks 1 and 16-20
|
This measure will be used to assess overall severity (CGI-S) and improvement (CGI-I) in adolescent ARFID. Total score range for each is 1-7. (Scores of 1 ("very much improved/normal") or 2 ("much improved/borderline ill") indicate a positive treatment response; all other responses are considered negative responses. Higher scores indicate worse outcome. |
Weeks 1 and 16-20
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Children's Food Neophobia Scale - six item version (CFNS-6)
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This measure of children's reluctance to try new or unfamiliar foods contains 6 items rated on a 4-point scale from 1 ("strongly disagree") to 4 ("strongly agree"), with 2 items reverse-scored. Total score range = 1 to 24, with higher scores indicating greater food neophobia. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Caregiver Strain Questionnaire (CGSQ)
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This scale will measure the strain caregivers experience as a result of their child's emotional and behavioral problems. It contains 21 items, each rated on a 5-point scale from 1 ("not at all a problem") to 5 ("very much a problem") for how much each occurrence or feeling was a problem in the past 6 months. The items form three subscales: objective strain (11 items), subjective internalized strain (6 items), and subjective externalized strain (4 items). Subscale and global scores are item means, 1 item ("relating well to child") is reverse scored. Scores range = 1 to 5, with higher scores indicating greater strain. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Parent-Rated Food Flexibility Scale (FFS)
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This scale is a 10-item parent-report measure of the child's tolerance of variability across food-related domains. Parents rate each domain on a 5-point scale from 0 ("very inflexible") to 4 ("very flexible"), with "mostly inflexible" (1), "some flexibility" (2), and "mostly flexible" (3) in between. Ratings are summed to a total score (range = 0 to 40), with higher scores indicating greater flexibility. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Acceptance and Confidence Scale - Anxiety
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This scale is a measure of the extent to which parents express acceptance of and confidence in the face of their child's anxiety, a key clinical target of SPACE. It contains 8 items, each rated on a 6-point scale from 1 ("strongly disagree") to 6 ("strongly agree"). Total score range = 8 to 48, with higher scores indicating greater acceptance and confidence. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Weekly Food Update
時間枠:Weeks 1-20
|
This brief questionnaire tracks changes in the child's eating over the course of treatment. Parents complete it before each weekly session, thinking back over the past week. The form has two parts. In the first, parents indicate whether their child ate each food already being tracked, and if so, how much (a taste, some, or a full portion), and whether the child now eats it regularly. In the second, parents record foods that are new that week: foods the child has never eaten before, foods the child is eating again after a long period of avoidance, and familiar foods eaten in a new way (for example, a different brand, preparation, or setting). |
Weeks 1-20
|
|
Parent-completed Glasgow Sensory Questionnaire, short form (rGSQ-P)
時間枠:Weeks 1, 8-10, 16-20 and 6 months later
|
This scale has 24 items and measures children's sensory hyper- and hypo-sensitivity across six sense domains (visual, auditory, gustatory, olfactory, tactile, vestibular). Parents rate items on a 5-point scale from 0 ("never") to 4 ("always"), yielding total (0-96), hyper-sensitivity (0-48), and hypo-sensitivity (0-48) scores, with higher scores indicating greater sensory sensitivity. |
Weeks 1, 8-10, 16-20 and 6 months later
|
|
Client Satisfaction Questionnaire (CSQ-8)
時間枠:Week 16-20
|
This 8-item measure assesses client satisfaction. Parents and adolescents rate items on a 0-4 scale, with higher summed scores indicating greater satisfaction with services (range = 0 to 32). |
Week 16-20
|
その他の成果指標
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Family Accommodation Scale - Anxiety (FASA-C/P)
時間枠:Weeks 1 and 16-20
|
This scale is a widely used measure of family accommodation. Adolescents and parents rate 9 items on a 5-point scale from 0 ("never") to 4 ("daily"). Total score range = 0 to 36. |
Weeks 1 and 16-20
|
|
Family Assessment Device - General Functioning Scale (FAD-GF)
時間枠:Weeks 1 and 16-20
|
This scale measures overall family functioning. Adolescents and parents rate 12-items on a 4-point scale from 0 ("strongly disagree") to 3 ("strongly agree"). Total score range = 0 to 36. |
Weeks 1 and 16-20
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Eli Lebowitz、Yale University
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- 2000044082
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。